Novel cancer therapy targeting microbiome.

Nagano, Tatsuya; Otoshi, Takehiro; Hazama, Daisuke; Kiriu, Tatsunori; Umezawa, Kanoko; Katsurada, Naoko; Nishimura, Yoshihiro

Nagano, Tatsuya; Otoshi, Takehiro; Hazama, Daisuke; Kiriu, Tatsunori; Umezawa, Kanoko; Katsurada, Naoko; Nishimura, Yoshihiro.

Afiliação

Nagano T; Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Otoshi T; Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Hazama D; Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Kiriu T; Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Umezawa K; Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Katsurada N; Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Nishimura Y; Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.

Onco Targets Ther ; 12: 3619-3624, 2019.

Article em En | MEDLINE | ID: mdl-31190864

Palavras-chave

antibiotics; dysbiosis; prebiotics; probiotics

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Onco Targets Ther Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Japão País de publicação: Nova Zelândia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google